Fortress Biotech Inc. (FBIOP)
6.63
-0.11 (-1.63%)
At close: Mar 24, 2025, 3:34 PM
6.63
0.00%
After-hours: Mar 24, 2025, 06:05 PM EDT
-1.63% (1D)
| Bid | 6.62 |
| Market Cap | 47.35M |
| Revenue (ttm) | 22.96M |
| Net Income (ttm) | -18.67M |
| EPS (ttm) | -0.863 |
| PE Ratio (ttm) | -7.68 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 6.73 |
| Volume | 3,755 |
| Avg. Volume (20D) | 12,613 |
| Open | 6.25 |
| Previous Close | 6.74 |
| Day's Range | 6.25 - 6.71 |
| 52-Week Range | 4.86 - 18.00 |
| Beta | 1.75 |
About FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 186
Stock Exchange NASDAQ
Ticker Symbol FBIOP
Website https://www.fortressbiotech.com
